Chennai, Sep 8 (SocialNews.XYZ) The Hyderabad based pharmaceutical major Natco Pharma Ltd on Friday said the company and others have been named as defendants in a case filed in the US.
In a regulatory filing Natco Pharma said, the company along with Celgene Corporation, Bristol Myers Squibb and Breckenridge Pharmaceutical Inc., have been named as defendants in an antitrust lawsuit in the US.
The suit was filed by Louisiana Health Service & Indemnity Company D/B/A Blue Cross and Blue Shield of Losisiana and HMO Louisiana Inc., regarding Pomalidomide (Pomalyst). Pomalidomide is a generic drug for cancer.
"Natco believes this matter is without merit. Breckenridge is the ANDA (abbreviated new drug application) holder and distribution partner for the generic product in the US," Natco said.
Meanwhile Natco Pharma's scrip that opened at Rs.917.75 on Friday went down and was changing hands at about Rs 882.
Source: IANS
About Gopi
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz